Meningioma
📧 Sign up to get email alerts when something new happens for Meningioma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-08-07Clinical Trial Update: Intraoperative Laser Speckle Contrast Imaging of Cerebral Blood Flow
Clinical trial update on using intraoperative laser speckle contrast imaging to monitor cerebral blood flow during brain procedures across s…
-
CLINICAL_TRIALS trial_result · 2024-08-06Clinical Trial Update: Combination of Alpelisib and Trametinib in Progressive Refractory Meningiomas [Phase 1]
Phase 1 clinical trial update for a combination of alpelisib and trametinib in progressive refractory meningiomas; study currently recruitin…
-
CLINICAL_TRIALS trial_result · 2024-06-18Clinical Trial Update: Gleolan for Visualization of Newly Diagnosed or Recurrent Meningioma [Phase 3]
Phase 3 trial evaluating Gleolan (5-aminolevulinic acid hydrochloride) for fluorescence-guided visualization during surgery for newly diagno…
-
CLINICAL_TRIALS trial_result · 2024-04-25Clinical Trial Update: Impact of External Drainage of the Lumbar Cistern in Patients With Hydrocephalus Following Meningioma Surgery and Its Influence on Patient Satisfaction
This clinical trial evaluated external drainage of the lumbar cistern to prevent postoperative hydrocephalus after meningioma surgery and as…
-
CLINICAL_TRIALS trial_result · 2023-12-22Clinical Trial Update: Interferon Alfa in Treating Patients With Recurrent Unresectable Meningiomas and Malignant Meningiomas [Phase 2]
Phase 2 trial update evaluating interferon alfa for recurrent unresectable meningiomas and malignant meningiomas has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-05-25Clinical Trial Update: Combination of Everolimus and Octreotide LAR in Aggressive Recurrent Meningiomas [Phase 2]
Phase 2 trial evaluating the combination of everolimus and octreotide LAR in aggressive recurrent meningiomas has completed.
-
CLINICAL_TRIALS trial_result · 2023-02-09Clinical Trial Update: Dosimetry-Guided, Peptide Receptor Radiotherapy (PRRT) With 90Y-DOTA- tyr3-Octreotide (90Y-DOTATOC) [Phase 2]
Phase 2 clinical trial evaluating dosimetry-guided PRRT with 90Y-DOTATOC in neuroendocrine tumors and meningioma; trial completed with resul…
-
CLINICAL_TRIALS trial_result · 2022-10-18Clinical Trial Update: Vistusertib (AZD2014) For Recurrent Grade II-III Meningiomas [Phase 2]
Phase 2 clinical trial update for vistusertib (AZD2014) in recurrent grade II-III meningioma.
-
CLINICAL_TRIALS trial_result · 2022-05-11Clinical Trial Update: Exploratory Evaluation of AR-42 Histone Deacetylase Inhibitor in the Treatment of Vestibular Schwannoma and Meningioma [EARLY_Phase 1]
An exploratory Phase 1 study evaluated the histone deacetylase inhibitor AR-42 in vestibular schwannoma and meningioma; the trial was termin…
-
CLINICAL_TRIALS trial_result · 2021-03-24Clinical Trial Update: T Cell Receptor Immunotherapy Targeting NY-ESO-1 for Patients With NY-ESO-1 Expressing Cancer [Phase 2]
Phase 2 trial update on T cell receptor immunotherapy targeting NY-ESO-1 in NY-ESO-1 expressing cancers; study is completed with results pos…
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: Hydroxyurea in Treating Patients With Recurrent and/or Unresectable Meningioma [Phase 2]
A Phase 2 clinical trial evaluating hydroxyurea for recurrent and/or unresectable meningioma has completed.
-
CLINICAL_TRIALS trial_result · 2021-02-03Clinical Trial Update: Radiation Therapy in Treating Patients Who Have Undergone Surgery for Newly Diagnosed Grade II or Grade III Meningioma [Phase 2]
Phase 2 trial of radiation therapy after surgery for newly diagnosed grade II or grade III meningioma.
-
CLINICAL_TRIALS trial_result · 2021-01-27Clinical Trial Update: Tranexamic Acid Reduce Blood Loss in Meningioma Resection [Phase 4]
Phase 4 clinical trial update investigating tranexamic acid to reduce blood loss during meningioma resection.
-
CLINICAL_TRIALS trial_result · 2021-01-22Clinical Trial Update: Bevacizumab in Treating Patients With Recurrent or Progressive Meningiomas [Phase 2]
Phase 2 clinical trial of bevacizumab in recurrent or progressive meningiomas completed; results posted.
-
CLINICAL_TRIALS trial_result · 2020-12-22Clinical Trial Update: AZD2014 In NF2 Patients With Progressive or Symptomatic Meningiomas [Phase 2]
Phase 2 trial update for AZD2014 in Neurofibromatosis 2 patients with progressive or symptomatic meningiomas has completed; results posted i…
-
CLINICAL_TRIALS trial_result · 2020-07-13Clinical Trial Update: Magnesium and Intraoperative Blood Loss in Meningioma Surgery [Phase 3]
Phase 3 trial assessing magnesium's effect on intraoperative blood loss in meningioma surgery has completed; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-06-18Clinical Trial Update: Stereotactic Body Radiotherapy for Spine Tumors [NA]
Clinical trial update on stereotactic body radiotherapy for spine tumors with completed status and results posted.
-
CLINICAL_TRIALS trial_result · 2020-04-20Clinical Trial Update: Peptide Receptor Radionuclide Therapy Administered to Participants With Meningioma With 67Cu-SARTATE™ [Phase 1, Phase 2]
Phase 1/2 trial investigating 67Cu-SARTATE for meningioma has completed.
-
CLINICAL_TRIALS trial_result · 2019-12-23Clinical Trial Update: S9005 Mifepristone in Meningioma [Phase 3]
Phase 3 trial update for S9005 mifepristone in meningioma has completed.
-
CLINICAL_TRIALS trial_result · 2018-07-03Clinical Trial Update: Yoga Therapy in Treating Patients With Malignant Brain Tumors [NA]
This entry notes a terminated clinical trial at Wake Forest evaluating yoga therapy for adults with malignant brain tumors.
-
CLINICAL_TRIALS trial_result · 2018-06-27Clinical Trial Update: Imatinib Mesylate in Treating Patients With Recurrent Malignant Glioma or Meningioma [Phase 1, Phase 2]
This update reports completion of a Phase 1/2 clinical trial evaluating Imatinib Mesylate in patients with recurrent malignant glioma or men…
-
CLINICAL_TRIALS trial_result · 2018-02-26Clinical Trial Update: Phase IV Bioseal Study in Brain Tumor Surgery [Phase 4]
Phase IV study evaluating Ethicon's Bioseal hemostatic sealant in meningioma brain tumor surgery has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-01-19Clinical Trial Update: Observation or Radiation Therapy in Treating Patients With Grade I, Grade II, or Grade III Meningioma [Phase 2]
Phase 2 trial evaluating observation or radiation therapy in patients with grade I-III meningioma; study completed with results posted in 20…
-
CLINICAL_TRIALS trial_result · 2017-07-13Clinical Trial Update: Erlotinib in Treating Patients With Recurrent Malignant Glioma or Recurrent or Progressive Meningioma [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating erlotinib in adults with recurrent malignant glioma or recurrent/progressive meningioma; the study is co…
-
CLINICAL_TRIALS trial_result · 2017-05-15Clinical Trial Update: Imatinib Mesylate in Treating Patients With Recurrent Meningioma [Phase 2]
Phase 2 trial evaluating imatinib mesylate in patients with recurrent meningioma completed; results posted in 2017.